The US Bankruptcy Court gave an order approving the sale of certain assets of Novan, Inc. on September 12, 2023. The debtor has been authorized to sell its certain assets to Mayne Pharma LLC, the winning bidder at the auction, for a purchase price of $8 million in cash with an earnest money deposit of $0.8 million. The debtor?s assets include certain Commercial Assets.